Low-dose naltrexone offers a great commitment to the millions of people all over the world dealing with autoimmune diseases, central nervous system disorders, or people facing deadly cancer. In such an innovative world, LDN can provide the initial cost-friendly, easy to take, and side-effect-free treatment for HIV/AIDS.
In 1984 FDA approved naltrexone itself in a dose of 50mg for the objective of treating heroin or opium abusers by obstructing the euphoric influence of such drugs. Through inhibiting opioid receptors, naltrexone further blocks the binding of the opioid hormones, which are produced in our brain and adrenal glands such as metenkephalin and beta-endorphin. Various tissues of the body own receptors for these enkephalins and endorphins, involving practically all the cells of the body’s immune system.
List of the diseases has it been helpful for:
Cancers
- Bladder Cancer
- Carcinoid
- Breast Cancer
- Colon & Rectal Cancer
- Liver Cancer
- Glioblastoma
- Lung Cancer (Non-Small Cell)
- Lymphoma (Hodgkin’s and Non-Hodgkin’s)
- Lymphocytic Leukemia (chronic)
- Multiple Myeloma
- Malignant Melanoma
- Neuroblastoma
- Pancreatic Cancer
- Ovarian Cancer
- Prostate Cancer
- Throat Cancer
- Renal Cell Carcinoma
- Uterine Cancer
Other Conditions
- Common Colds (URI’s)
- HIV/AIDS
- Emphysema (COPD)
- Lyme Disease (Late Stage)
- Depression (Major and Bipolar)
Neurodegenerative:
- ALS (Lou Gehrig’s Disease)
- Autism Spectrum Disorders
- Alzheimer’s Disease
- Multiple Sclerosis (MS)
- Hereditary Spastic Paraparesis
- Parkinson’s Disease
- Post-Traumatic Stress Disorder (PTSD)
- Post-Polio Syndrome
- Progressive Supranuclear Palsy
- Primary Lateral Sclerosis (PLS)
- Transverse Myelitis
Other Autoimmune Diseases:
- Behcet’s Disease
- Ankylosing Spondylitis
- Crohn’s Disease
- Celiac Disease
- CREST syndrome
- Chronic Fatigue Syndrome
- Dermatomyositis
- Endometriosis
- Dystonia
- Hashimoto’s Thyroiditis
- Fibromyalgia
- Irritable Bowel Syndrome (IBS)
- Nephrotic Syndrome
- Myasthenia Gravis (MG)
- Pemphigoid
- Psoriasis
- Primary Biliary Cirrhosis
- Stiff Person Syndrome (SPS)
- Sarcoidosis
- Rheumatoid Arthritis
- Scleroderma
- Sjogren’s Syndrome
- Ulcerative Colitis
- Systemic Lupus (SLE)
- Wegener’s Granulomatosis
How can one medicine influence such an extensive range of disorders?
All the disorders mentioned above share a common feature which is, in each of them the immune system performs a fundamental role. Low levels of endorphins in the blood are usually present, adding to the disease-associated immune deficiencies.
Researches on neuropeptide receptors revealed by several human tumors have discovered opioid receptors in various types of cancer:
- Brain tumors
- Lung cancer
- Head and neck squamous cell carcinoma
- Breast cancer
- Myeloid leukemia
- Endometrial cancer
- Neuroblastoma and others
These discoveries suggest the likelihood of an advantageous low-dose naltrexone outcome in a broad range of common cancers.
LDN has shown effectiveness in the treatment of numerous cases
Cancer
During the mid of 2004, Dr. Bihari claimed of having treated more than 300 cancer patients who did not respond to regular treatments. From that group, around 50% of patients, following 4 to 6 months of treatment using low-dose naltrexone, started to exhibit a cessation in the growth of cancer and, among those, over 1 3rd have displayed objective indications of tumor shrinkage.
Autoimmune diseases
In the group of subjects who came forward with an autoimmune disease, none of them were unsuccessful in responding to low dose naltrexone, everyone experienced a pause in the progress of their disease. In several patients, a marked reduction in indications and symptoms of the disease were observed. The highest fraction of patients in the autoimmune disorder group is the individuals having multiple sclerosis. Fewer than 1% of those patients ever encountered a new attack of multiple sclerosis while maintaining their daily LDN nightly therapy.
HIV/AIDS
Since 2003, Dr. Bihari had been using low-dose naltrexone in combination with trusted AIDS therapies to treat 350 AIDS patients. Over the previous 7 years, more than 85% of those patients revealed no HIV detectable levels, and it is considered a much greater success rate as compared to most prevailing AIDS treatments and includes no notable side effects. It is additionally worth remarking that several HIV/AIDS subjects have been surviving symptom-free over several years using only low-dose naltrexone with no additional medicines.
Central Nervous System disorders
Anecdotal statements remain being received concerning helpful consequences of LDN for the treatment of Parkinson’s disease, Amyotrophic lateral sclerosis (ALS—Lou Gehrig’s disease), Alzheimer’s disease, and primary lateral sclerosis. Dr. Jaquelyn McCandless claims to have found a highly positive impact of LDN, in the suitably reduced dose and applied topically as a transdermal cream in kids having autism.
LDN should be made by a well-reputed compounding pharmacy
Naltrexone is a prescription medicine, so your doctor would have to provide you a prescription after he/she decides that LDN seems suitable for you.
Low dose naltrexone prescriptions are presently being filled by a number of local compounding pharmacies, and also by mail-order pharmacies, all over the US. Some pharmacists have been crushing up the 50mg naltrexone tablets to make the 4.5mg LDN capsules, while others make use of naltrexone, obtained from a primary manufacturer as a pure powder. Never attempt to divide naltrexone tablets by yourself to create low-dose naltrexone. Your consultant can assist you to locate a compounding pharmacy, such as Harbor Compounding Pharmacy, which prepares Low Dose Naltrexone.
